Yahoo
NasdaqGM - Delayed Quote USD

Drugs Made In America Acquisition II Corp. (DMII)

10.21 -0.01 (-0.10%)
At close: November 6 at 4:00:00 PM EST
Trade DMII on Coinbase

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Roger Bendelac
Chief Executive Officer -- -- 1957
Mr. Saleem Elmasri C.P.A.
CFO & Principal Accounting Officer -- -- 1986

Drugs Made In America Acquisition II Corp.

420 Lexington Avenue
Suite 1402
New York, NY 10170
United States
917 982 4565
Sector: 
Financial Services
Industry: 
Shell Companies

Description

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.

Corporate Governance

Drugs Made In America Acquisition II Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

August 14, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 14, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 28, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 15, 2026 at 12:00 AM UTC

10-K: Periodic Financial Reports

April 3, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 1, 2026 at 12:00 AM UTC

NT 10-K: Periodic Financial Reports

March 17, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 6, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 18, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 17, 2025 at 12:00 AM UTC

NT 10-Q: Periodic Financial Reports

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: